PARAFLEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paraflex, and when can generic versions of Paraflex launch?
Paraflex is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in PARAFLEX is chlorzoxazone. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Paraflex
A generic version of PARAFLEX was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PARAFLEX?
- What are the global sales for PARAFLEX?
- What is Average Wholesale Price for PARAFLEX?
Summary for PARAFLEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 109 |
| Patent Applications: | 4,171 |
| DailyMed Link: | PARAFLEX at DailyMed |
US Patents and Regulatory Information for PARAFLEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | PARAFLEX | chlorzoxazone | TABLET;ORAL | 011300-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
